Skip to main content
Dryad

Human primary mesothelial cells treated with TGF-β1 and with or without JPH203

Data files

Sep 13, 2024 version files 23.73 GB

Select up to 11 GB of files for download

Abstract

The mesothelial-mesenchymal transition (MMT) of mesothelial cells has been recognized as a critical process during progression of peritoneal fibrosis (PF). Despite its crucial role in amino acid transport and metabolism, the involvement of LAT1 and the potential therapeutic role of its inhibitor, JPH203, in fibrotic diseases remain unexplored.